AzTrials
AzTrials

Behavior Change InterventionsNCT06950528

Monocular-Camera-Based Mobile Exergame for Type 2 Diabetes Prevention

A study testing Kinect group and Monocular group in people with Behavior Change Interventions, run by Shanghai Jiao Tong University School of Medicine at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Exergames have demonstrated potential as effective interventions for promoting physical activity and preventing type 2 diabetes (T2D), particularly among older adults. Kinect-based exergames, in particular, have been associated with improved adherence to exercise regimens and positive health outcomes. Read more about this study

Who is it for?
Ages 60 to 74 yearsHealthy volunteers can take part
Conditions the study is for
Behavior Change Interventions
What is being tested?
Kinect group and Monocular group
Could I receive a placebo?
No, everyone receives an active treatment
How many people
45 participants
Where
1 siteChina
Study dates
1 Jan 2024to 1 Aug 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 to 74 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • age between 60-74;
  • a score of 25 or higher on the Chinese Diabetes Risk Score;
  • community-dwelling individuals, not reside in assisted living or long-term care facilities;
  • physically capable of engaging in light to moderate exercise, as determined by self-report and/or physician clearance;
  • normal cognitive function that enable the participant to complete the experiment independently or with minimal assistance;
  • Written informed consent provided by participants or their families.

Who cannot join

  • diagnosis of type 1 or type 2 diabetes;
  • current participation in another exercise intervention study;
  • severe cognitive impairment with MMSE < 24;
  • major mobility limitations such as severe osteoarthritis and recent orthopedic surgery.

Trial locations and contacts

1 site in 1 country.

China1 site
  • Hongqiao Community

    Shanghai, Shanghai Municipality, 200240

Other trials in China

About this study

Official title: Development and Evaluation of a Monocular-Camera-Based Mobile Exergame for At-Home Intervention in Individuals at High Risk of Type 2 Diabetes

Exergames have demonstrated potential as effective interventions for promoting physical activity and preventing type 2 diabetes (T2D), particularly among older adults. Kinect-based exergames, in particular, have been associated with improved adherence to exercise regimens and positive health outcomes. However, widespread implementation is limited by the high cost and reduced accessibility of the required hardware, restricting their use in home-based settings. Recent advances in computer vision have enabled the development of exergames using monocular camera systems, which may represent a cost-effective and scalable alternative. This study investigates the feasibility of monocular-camera-based exergames as a cost-effective and convenient alternative for home-dwelling individuals.

A total of 45 community-dwelling older adults aged 60-74 years, identified as high risk for T2D were recruited through local community health centers. Participants were randomly assigned to one of three groups (n = 15 per group): (1) Control group (traditional offline exercise with printed instructions), (2) Kinect group (Kinect-based exergames targeting aerobic capacity, balance, and strength), and (3) Monocular group (monocular-camera-based exergames using real-time 2D pose estimation). The intervention lasted six weeks, with participants completing three 30-minute sessions per week at home. Primary outcomes included exercise performance (completion rate and movement accuracy) and intrinsic motivation. Secondary outcomes included perceived enjoyment, challenge, and usability. Data were analyzed using one-way ANOVA.

Being tested
Control group, Kinect group, Monocular group
Keywords
Exergame, Individuals at High Risk of Type 2 Diabetes

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Control groupBehavioural

    Control Group consists of six motion videos, including: crossover steps, high knees, lateral raises, punching movements, downward leg punches from a standing position, and elbow-to-chest expansions

  • Kinect groupBehavioural

    Kinect Group features the same software functionality and design as the application based on bullet-screen cameras, but the hardware is built using a Kinect sensor. The gamified platform is primarily developed and presented using Unity software. The Kinect 3D motion-sensing camera incorporates real-time dynamic capture and image recognition capabilities, offering new possibilities for interactive approaches to motion therapy

  • Monocular groupBehavioural

    The game employs a virtual avatar to replicate users' movements, thereby fostering an immersive and engaging experience. A monocular camera captures users' movements in real time, which are analyzed through pose estimation algorithms and subsequently mapped onto the virtual avatar. Users interact with the game by following on-screen visual demonstrations, presented as either static images or animations, to perform the prescribed exercises. Movement accuracy is evaluated by the system, with scores awarded based on performance. To enhance user motivation and adherence, the game incorporates a reward system, where points earned through accurate execution can be redeemed for in-game rewards, such as unlocking background music, avatar customization options, and new virtual environments.

Study groups in NCT06950528
Study groupRoleWhat they receive
Control groupActive comparatorReceive traditional offline exercise with printed instructions
Receives: Behavioral: Control group
Kinect groupActive comparatorUse Kinect based mobile exergame
Receives: Behavioral: Kinect group
Monocular groupExperimentalUsed monocular-camera-based exergame
Receives: Behavioral: Monocular group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Heart rate

    The post-intervention heart rate was collected during the first 10 seconds post-exercise to estimate physiological responses. Considering the general physical condition of individuals at high risk of diabetes, the study used 50%-80% of the maximum heart rate as the target exercise intensity. The maximum heart rate was calculated using the formula: 208 - (age × 0.7).

    Measured: Baseline, Immediately after the intervention

  2. Perceived fatigue

    perceived fatigue, a widely accepted parameter in exercise assessments for diabetes-related fields, was employed to supplement the evaluation of physical activity. The Borg RPE (Rating of Perceived Exertion) scale[18], ranging from 6 to 20, was utilized to assess subjective fatigue and compare perceived exercise intensity across groups.

    Measured: Baseline, Immediately after the intervention

Secondary outcomes (3)
  1. Game experience

    At the first session of intervention, participants in the Kinect and monocular groups completed the Game Experience Questionnaire (GEQ) to assess their user experience[19]. The GEQ was used to evaluate and compare the impact of different technologies on immersion and the overall experience of exergames.

    Measured: Immediately after the intervention

  2. Intrinsic motivation

    Furthermore, the Interest/Enjoyment Subscale of the Intrinsic Motivation Inventory (IMI) was administered to participants in the control group, Kinect group, and monocular group[20]. This subscale evaluated and compared intrinsic motivation and enjoyment associated with physical activity across the three groups.

    Measured: Immediately after the intervention

  3. User engagement

    At the end of one-week experiment period, user engagement was further quantified by tracking the frequency of intervention use over the one-week period, based on participants' video-recorded usage logs.

    Measured: Follow-up (one week after the intervention)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Apr 2025
  2. Study start1 Jan 2024
  3. Primary completion30 Jun 2024
  4. Study completion1 Aug 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
45 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06950528
Sponsor's protocol ID
SRSY202504100034
Status last verified
Apr 2025
First submitted
10 Apr 2025
Last updated
30 Apr 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: The information might be shared after the research group finished the data analysis process.

Questions about this trial

What is this clinical trial studying?

A study testing Kinect group and Monocular group in people with Behavior Change Interventions, run by Shanghai Jiao Tong University School of Medicine at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Heart rate (time frame: Baseline, Immediately after the intervention). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Apr 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in